Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,598 | 704 | 95.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $287.86 | 13 | 2.6% |
| Education | $236.03 | 6 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,052 | 96 | $0 (2021) |
| GENZYME CORPORATION | $826.44 | 45 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $815.91 | 59 | $0 (2023) |
| Amgen Inc. | $636.01 | 35 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $584.13 | 24 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $539.66 | 37 | $0 (2021) |
| Eisai Inc. | $534.26 | 34 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $497.48 | 34 | $0 (2021) |
| EMD Serono, Inc. | $473.01 | 27 | $0 (2021) |
| Biogen, Inc. | $403.66 | 27 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $437.59 | 12 | Alexion Pharmaceuticals, Inc. ($163.51) |
| 2023 | $108.41 | 4 | Alexion Pharmaceuticals, Inc. ($50.00) |
| 2022 | $90.83 | 6 | ABBVIE INC. ($27.02) |
| 2021 | $1,976 | 125 | Biogen, Inc. ($178.35) |
| 2020 | $2,533 | 167 | Allergan, Inc. ($256.73) |
| 2019 | $2,561 | 174 | Novartis Pharmaceuticals Corporation ($392.54) |
| 2018 | $1,735 | 116 | GENZYME CORPORATION ($302.20) |
| 2017 | $1,680 | 119 | Allergan Inc. ($291.18) |
All Payment Transactions
723 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Immunology | ||||||
| 09/19/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $86.00 | General |
| Category: NEUROLOGY | ||||||
| 09/17/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 09/16/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Neurology | ||||||
| 08/13/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Neurology | ||||||
| 07/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $13.51 | General |
| Category: Rare Disease | ||||||
| 05/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $50.00 | General |
| Category: Rare Disease | ||||||
| 04/08/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 02/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: PAIN | ||||||
| 04/05/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $50.00 | General |
| Category: Rare Disease | ||||||
| 01/09/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Neurology | ||||||
| 01/04/2023 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: Neurology | ||||||
| 10/27/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2022 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $12.21 | General |
| Category: Neurology | ||||||
| 05/03/2022 | LivaNova USA, Inc. | VNS Therapy SenTiva Model 1000 Generator (Device) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/14/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Neurology | ||||||
| 03/16/2022 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Neurology | ||||||
| 02/28/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 672 | 808 | $244,001 | $93,656 |
| 2022 | 5 | 490 | 629 | $165,384 | $67,187 |
| 2021 | 5 | 543 | 729 | $189,223 | $75,605 |
| 2020 | 5 | 558 | 729 | $188,554 | $65,525 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 293 | 422 | $94,950 | $37,862 | 39.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 192 | 192 | $85,056 | $30,686 | 36.1% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 36 | 36 | $18,396 | $7,744 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $23,270 | $7,714 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 54 | $16,362 | $7,277 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 39 | $5,967 | $2,373 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 278 | 416 | $93,600 | $39,934 | 42.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 101 | 101 | $36,158 | $12,919 | 35.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 56 | 56 | $24,808 | $9,382 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 41 | $6,273 | $2,771 | 44.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 15 | $4,545 | $2,181 | 48.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 329 | 508 | $114,300 | $47,007 | 41.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 98 | 98 | $43,414 | $16,682 | 38.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 48 | 48 | $17,184 | $5,783 | 33.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 56 | $8,568 | $3,531 | 41.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 19 | $5,757 | $2,602 | 45.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 348 | 516 | $116,100 | $40,276 | 34.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 104 | 104 | $46,072 | $16,514 | 35.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 36 | $10,908 | $3,693 | 33.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 52 | $7,956 | $2,839 | 35.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 21 | 21 | $7,518 | $2,202 | 29.3% |
About Dr. Christine Pierre, MD
Dr. Christine Pierre, MD is a Neurology healthcare provider based in Jacksonville Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1548418700.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christine Pierre, MD has received a total of $11,122 in payments from pharmaceutical and medical device companies, with $437.59 received in 2024. These payments were reported across 723 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($10,598).
As a Medicare-enrolled provider, Pierre has provided services to 2,263 Medicare beneficiaries, totaling 2,895 services with total Medicare billing of $301,973. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Jacksonville Beach, FL
- Active Since 08/29/2008
- Last Updated 07/23/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1548418700
Products in Payments
- Aimovig (Biological) $580.34
- Fycompa (Drug) $512.02
- GOCOVRI (Drug) $497.48
- AUBAGIO (Drug) $440.30
- NUEDEXTA (Drug) $416.22
- AIMOVIG (Biological) $390.52
- LEMTRADA (Drug) $386.14
- BOTOX (Biological) $359.41
- Briviact (Drug) $344.05
- TYSABRI (Biological) $306.68
- TROKENDI XR (Drug) $303.60
- OCREVUS (Biological) $302.59
- UBRELVY (Drug) $276.67
- VRAYLAR (Drug) $260.32
- SOLIRIS (Drug) $245.49
- ACTHAR (Biological) $225.51
- AJOVY (Biological) $223.49
- ZEPOSIA (Drug) $223.48
- ULTOMIRIS (Biological) $213.51
- INBRIJA (Drug) $183.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Jacksonville Beach
Thomas Snyder, Md, MD
Neurology — Payments: $340,171
Dr. Robert Mannel, M.d, M.D
Neurology — Payments: $52,844
Dr. Michael Todinca, M.d, M.D
Neurology — Payments: $4,512
Dr. Michelle Nunes Caravaglio, Md, MD
Neurology — Payments: $2,734
Richard Boehme, Md, MD
Neurology — Payments: $2,084
Dr. Karen Thalinger, Md, MD
Neurology — Payments: $950.12